Home/Filings/4/0000914190-21-000241
4//SEC Filing

Hastings John M. 4

Accession 0000914190-21-000241

CIK 0001180145other

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 7:16 PM ET

Size

8.7 KB

Accession

0000914190-21-000241

Insider Transaction Report

Form 4
Period: 2021-08-09
Hastings John M.
VP Manufacturing & Operations
Transactions
  • Award

    Common Stock

    2021-08-09+4,07740,478 total
  • Award

    Common Stock

    2021-08-09+12,23152,709 total
Footnotes (3)
  • [F1]Restrictions lapse as to 1,359 shares on each of 8/13/22, 8/13/23 and 8/13/24.
  • [F2]Subject to performance-based forfeiture based on the Company's three-year total shareholder return for fiscal years 2022, 2023 and 2024 versus the Company's peer group.
  • [F3]Includes 110 shares acquired on 12/31/20 and 69 shares acquired on 6/30/21 pursuant to the Company's Employee Stock Purchase Plan.

Issuer

Cardiovascular Systems Inc

CIK 0001180145

Entity typeother

Related Parties

1
  • filerCIK 0001781460

Filing Metadata

Form type
4
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 7:16 PM ET
Size
8.7 KB